ISSUE 85 I AUGUST 2019

Taming the

pharma beast

How can Big Pharma move the industry away from patents to become more patient-focused? 

How do cancer cells communicate?

Danger: unlicensed stem cell clinics 

Understanding drug-resistant TB

In association with

07/29/2019 14:28:36
  • Home | Taming the pharma beast
  • In this issue
  • Emirates SkyCargo
  • Contents
  • TSS Company Insight
  • News
  • Daiichi Jitsugyo
  • ICCI Company Insight
  • ICCI
  • The pharma industry briefing
  • Novo Nordisk
  • Swiss WorldCargo
  • Understanding drug-resistant TB
  • CBDepot Company Insight
  • CBDepot
  • Through time: the breakthroughs that changed the course of HIV treatment
  • Senn Chemicals
  • Qatar Airways
  • Trouble at Teva: US price-fixing lawsuit adds to generic giant’s woes
  • Accurate Biometrics Company Insight
  • Accurate Biometrics
  • The dangers of unlicensed stem cell clinics
  • Komtur Pharmaceuticals
  • How do cancer cells communicate and can it help us catch them?
  • Verona’s ensifentrine: a potentially revolutionary treatment for COPD
  • Taming the pharma monster with Hedley Rees
  • Capsugel Company Insight
  • Altheria Solutions
  • ‘Pay As You Go’ AI for drug discovery
  • AtoZ-CRO GmbH
  • PharmaHemp
  • Event: CPhl Korea
  • Events
  • Centaur Clinical | Company Insight
  • Centaur Clinical
  • Next issue
  • Hapa Company Insight
  • Pfanstiehl